Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Jul-Sep;1(3):348-54.

Disabling pansclerotic morphea of childhood--unusual case and management challenges

Affiliations
Case Reports

Disabling pansclerotic morphea of childhood--unusual case and management challenges

Ana-Maria Forsea et al. J Med Life. 2008 Jul-Sep.

Abstract

Morphea, also known as localized scleroderma is a chronic disease of unknown etiology, characterized by fibrous deposition and obliteration of vessels in the skin. This disease has a wide clinical spectrum, ranging from mild hyperpigmented plaques to severe, invalidating generalized and pansclerotic forms. Disabling pansclerotic morphea of childhood is a rare and debilitating variant of localized scleroderma, characterized by a rapid progression of deep cutaneous fibrosis that involves the dermis and the subcutaneous adipose tissue but also fascia, muscles, and bone. Contractures and musculoskeletal atrophy develop and the disease has an invalidating and even fatal course. We present an unusual case of severe morphea in a 19-year-old girl, with a polymorphous clinical picture consisting of plaques, linear and pansclerotic, circumferential lesions, with symmetric, invalidating involvement of all limbs and explosive evolution with centripetal progression. This case emphasizes the unpredictable character of morphea evolution, the possible severe prognosis and the therapeutic challenges raised by the generalized, disabling forms of this disease.

PubMed Disclaimer

Figures

Fig.1
Fig.1
disseminated hyperpigmented sclero-atrophic plaques on the chest and flanks, moderate atrophy of left breast caused by fibrotic process and discrete limitation of the extension of elbows (maximal 150 degrees)
Fig.2
Fig.2
linear sclero-atrophic lesions on posterior left hemitorax, following Blashko’s lines and on posterior side of left arm
Fig.3
Fig.3
delineation of linear lesions on both inferior limbs
Fig.4
Fig.4
extended hyperpigmented sclero-atrophic plaques on flanks and chest, with indurations and severe atrophy of the left breast and sclerosis involving all the surface of forearms and elbows up to distal third of the arms; fixation of elbows at 90 degrees flexion; fibrous bands extended to the left shoulder
Fig.5
Fig.5
pansclerotic lesions with important atrophy of the underlying muscles and immobilization in semi-flexion of the fingers of both hands and first, with the absence of cutaneous fold; severe limitation of the mobility of the wrists
Fig.6
Fig.6
extended sclero-atrophic lesions with indurations and atrophy on the surface of the legs, with sclerotic bands extending over the knees to the proximal thighs

Similar articles

Cited by

  • Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Soh HJ, Samuel C, Heaton V, Renton WD, Cox A, Munro J. Soh HJ, et al. Rheumatol Int. 2019 May;39(5):933-941. doi: 10.1007/s00296-019-04269-w. Epub 2019 Mar 5. Rheumatol Int. 2019. PMID: 30838436 Review.
  • Phototherapy in Scleroderma.
    Hassani J, Feldman SR. Hassani J, et al. Dermatol Ther (Heidelb). 2016 Dec;6(4):519-553. doi: 10.1007/s13555-016-0136-3. Epub 2016 Aug 12. Dermatol Ther (Heidelb). 2016. PMID: 27519050 Free PMC article. Review.
  • Disabling pansclerotic morphoea of childhood.
    Jamalpur I, Mogili HR, Koratala A. Jamalpur I, et al. BMJ Case Rep. 2018 Feb 17;2018:bcr2017222132. doi: 10.1136/bcr-2017-222132. BMJ Case Rep. 2018. PMID: 29455178 Free PMC article.
  • Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
    Baghdassarian H, Blackstone SA, Clay OS, Philips R, Matthiasardottir B, Nehrebecky M, Hua VK, McVicar R, Liu Y, Tucker SM, Randazzo D, Deuitch N, Rosenzweig S, Mark A, Sasik R, Fisch KM, Pimpale Chavan P, Eren E, Watts NR, Ma CA, Gadina M, Schwartz DM, Sanyal A, Werner G, Murdock DR, Horita N, Chowdhury S, Dimmock D, Jepsen K, Remmers EF, Goldbach-Mansky R, Gahl WA, O'Shea JJ, Milner JD, Lewis NE, Chang J, Kastner DL, Torok K, Oda H, Putnam CD, Broderick L. Baghdassarian H, et al. N Engl J Med. 2023 Jun 15;388(24):2241-2252. doi: 10.1056/NEJMoa2202318. Epub 2023 May 31. N Engl J Med. 2023. PMID: 37256972 Free PMC article.
  • Adult-onset unilateral disabling pansclerotic morphea.
    Singh A, Singhal K, Choudhary S, Bisati S, Arora M. Singh A, et al. Indian J Dermatol. 2014 May;59(3):316. doi: 10.4103/0019-5154.131459. Indian J Dermatol. 2014. PMID: 24891683 Free PMC article.

References

    1. Black CM. Scleroderma and fasciitis in children. Curr Opin Rheumatol. 1995;7:442–448. - PubMed
    1. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma) Mayo Clin Proc. 1995 Nov;70(11):1068–1076. - PubMed
    1. Irwin M. Freedberg, Arthur Z. Eisen, Klauss Wolff, K. Frank Austen, Lowell A. Goldsmith, Stephen Katz. Fitzpatrick's Dermatology in General Medicine
    1. Tony Burns, Stephen Breathnach, Neil Cox, Christopher Griffiths. Rook's Textbook of Dermatology
    1. Diaz-Perez JL, Connolly SM, Winkelmann RK. Disabling pansclerotic morphea of children. Arch Dermatol . 1980;116:169–173. - PubMed

Publication types

MeSH terms

LinkOut - more resources